A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
Conditions
KRAS G12D Mutation · Advanced Solid Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Clinical Trial Site, Phoenix, Arizona, United States
Clinical Trial Site, Phoenix, Arizona, United States
Clinical Trial Site, New Haven, Connecticut, United States
Clinical Trial Site, Tampa, Florida, United States
Clinical Trial Site, Indianapolis, Indiana, United States
Clinical Trial Site, Grand Rapids, Michigan, United States
Clinical Trial Site, New York, New York, United States
Clinical Trial Site, New York, New York, United States
Clinical Trial Site, Huntersville, North Carolina, United States
Clinical Trial Site, Cleveland, Ohio, United States
Clinical Trial Site, Houston, Texas, United States
Clinical Trial Site, San Antonio, Texas, United States
Clinical Trial Site, Salt Lake City, Utah, United States
Clinical Trial Site, Fairfax, Virginia, United States